Critical role of SEMA5A expression in invasion and metastasis of ovarian cancer cell


Downloads: 685
Dan G. Wang1, Nasser Ghaly Yousif2, Alaa Muhammad Sadiq3, Mary M. Schilling1, Alex J Danielson1*
Author Affiliations
∗Correspondence author e-mail: Alex.Danielson@yahoo.com: 1University of Hawaii at Manoa, Manoa, HI. 2Colorado University. 3Kufa University

 

Abstract

Semaphorins are a large family of genes involved in the development and morphogenesis of the nervous system. SEMA5A has been reported as a bi-functional molecule, acting as both oncogene and tumor suppressor in different types of cancer. High expression levels of SEMA5A and its receptor, Plexin-B3, were associated with aggressiveness in pancreatic and prostate cancers. Our previous study in ovarian cancer metastasis indicates that FAK knock-down can suppress ovarian cancer cells migration and invasion. We hypothesized that SEMA5A expression promotes ovarian cancer invasion and metastasis. We investigated the expression of SEMA5A in patients with metastatic ovarian cancer (n = 43), localized tumor (n = 37) and normal ovarian tissue (n = 12) from non-malignant diseases as control with different histopathological characteristics. For Silencing of SEMA5A in vitro, we treated human ovarian cancer cells (OVCAR-3, A2780/CP70) with miR-27a and miR-27b. We observed significantly higher expression of SEMA5A protein (P= 0.001) in metastatic ovarian cancer tissue associated with poor overall survival outcomes compared to localized ovarian cancer and control. In vitro silencing of SEMA5A reduced migration and invasion of ovarian cancer cell. Our data offer opportunities for the therapeutic modulation and biomarker of metastatic ovarian cancer.

Keywords: Semaphorin, SEMA5A, Plexin-B3, FAK, Ovarian cancer

Copyright © 2016 by The American Society for BioMedicine and BM-Publisher, Inc.

Article citationReferencesFull-Text/PDFBecome reviewer
The citation data is computed by the following citation measuring services:

Google scholarcitedby

References

  1. Goodman CS, Kolodkin AL, Luo Y, Püschel AW, Raper JA. Unified Nomenclature for the Semaphorins/Collapsins. Cell 1999;97:551–552. doi: 1016/S0092-8674(00)80766-7. [PubMed] [Cross Ref]
  2. Flannery E, Duman-Scheel M. Semaphorins at the interface of development and cancer. Curr Drug Targets. 2009;10:611–619. [PubMed]
  3. Oinuma I, Ishikawa Y, Katoh H, Negishi M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science. 2004;305:862–865. doi: 10.1126/science.1097545. [PubMed] [Cross Ref]
  4. Basile JR, Barac A, Zhu T, Guan K-L, Gutkind JS. Class IV Semaphorins Promote Angiogenesis by Stimulating Rho-Initiated Pathways through Plexin-B. Cancer Res. 2004;64:5212–5224. doi: 10.1158/0008-5472.CAN-04-0126. [PubMed] [Cross Ref]
  5. JR, Castilho RM, Williams VP, Gutkind JS. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA. 2006;103:9017–9022. doi: 10.1073/pnas.0508825103. [PubMed] [Cross Ref]
  6. Artigiani S, Barberis D, Fazzari P, Longati P, Angelini P, van de Loo J-W, Comoglio PM, Tamagnone L. Functional Regulation of Semaphorin Receptors by Proprotein Convertases. J Biol Chem. 2003;278:10094–10101. doi: 10.1074/jbc.M210156200. [PubMed] [Cross Ref]
  7. Oinuma I, Katoh H, Negishi M. Semaphorin 4D/Plexin-B1-mediated R-Ras GAP activity inhibits cell migration by regulating β1 integrin activity. J Cell Biol. 2006;173:601–613. doi: 10.1083/jcb.200508204. [PMC free article] [PubMed] [Cross Ref]
  8. Tamagnone L, Comoglio PM. To move or not to move? Semaphorin signalling in cell migration. EMBO Rep. 2004; 5:356–361. [PubMed]
  9. Serini G,  Zanivan VS, Morterra G, Burkhardt C, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature. 2003; 424:391–397. [PubMed]
  10. Oinuma, I, Ishikawa Y, Katoh H, Negishi M. The semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 2004; 305:862–865. [PubMed]
  11. Kolodkin AL, Matthes DL, Goodman CS. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75:1389–1399. [PubMed]
  12. Basile JR, Afkhami T, Gutkind JS. Semaphorin 4D/Plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol. Cell. Biol 2005; 25:6889–6898. [PMC free article] [PubMed]
  13. Aurandt J, Vikis HG, Gutkind JS, Ahn N, Guan KL. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc. Natl. Acad. Sci. USA 2002; 99:12085-12090. [PubMed]
  14. Bates D, Taylor GI, Minichiello J, Farlie P, et al. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev. Biol 2003; 255:77-98. [PubMed]
  15. Rohm B, Rahim B, Kleiber B, et al. The semaphorin 3A receptor may directly regulate the activity of small GTPases. FEBS Lett 2000; 486:68-72. [PubMed]
  16. Shoji W, Isogai S, Sato-Maeda M, et al. Semaphorin3a1 regulates angioblast migration and vascular development in zebrafish embryos. Development 2000;130:3227-3236. [PubMed]
  17. Amagnone L, Comoglio PM. To move or not to move? Semaphorin signalling in cell migration. EMBO Rep. 2004; 5:356-361. [PubMed]
  18. Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, et al. Semaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases. Cancer Res. 2008; 68: 6922–6931. [PubMed]
  19. Tse C, Xiang RH, Bracht T, Naylor SL. Human Semaphorin 3B (SEMA3B) Located at Chromosome 3p21.3 Suppresses Tumor Formation in an Adenocarcinoma Cell Line. Cancer Res. 2002; 62: 542–546. [PubMed]
  20. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature. 2003;424:391–397. [PubMed]
  21. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, et al. Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis. J Biol Chem. 2007; 282: 26294–26305. [PubMed]
  22. Neufeld G, Cohen T, Shraga N, et al. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 2002;12:13–19. [PubMed]
  23. Yousif NG. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway. Cell Biol Int. 2014;38(1):85-91.[PubMed]
  24. Sun Q, Zhou H, Binmadi NO, Basile JR. Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J Biol Chem 2009;284:32066–32074. [PubMed]
  25. Ventura A, Pelicci PG. Semaphorins: green light for redox signaling? Sci STKE 2002;2002: PE44. [PubMed]
  26. Casazza A, Finisguerra V, Capparuccia L, et al. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J Clin Invest 2010;120:2684–2698. [PMC free article] [PubMed]
  27. Sadanandam A, Rosenbaugh EG, Singh S, Varney M, Singh RK. Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc. Res 2010;79:1–9. [PubMed] [Cross Ref]
  28. Zhou Y, Gunput RA, Pasterkamp RJ. Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 2008;33:161–170. [PubMed] [Cross Ref]
  29. Suzuki K, Okuno T, Yamamoto M, et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007;446:680–684.[PubMed] [Cross Ref]
  30. Basile JR, Barac A, Zhu T, Guan K, Gutkind JS. Class IV Semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004;64:5212–5224. [PubMed]
  31. Zhou H, Yang YH, Binmadi NO, Proia P, Basile JR. The hypoxia-inducible factor-responsive proteins semaphorin 4D and vascular endothelial growth factor promote tumor growth and angiogenesis in oral squamous cell carcinoma. Exp. Cell Res 2012;318:1685–1698. [PMC free article] [PubMed]
  32. Sakurai A, Doçi CL, Gutkind JS. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res 2012;22:23–32. [PMC free article] [PubMed]
  33. Bielenberg DR, Klagsbrun M. Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 2007;26: 421–431. [PubMed]
  34. Rolny C, Capparuccia L, Casazza A, et al. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment. J Exp Med 2008;205:1155–1171. [PMC free article] [PubMed]
  35. Polleux F, Morrow T, Ghosh A. Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 2000;404:567–573. [PubMed]
  36. Miao HQ, Soker S, Feiner L, et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999;146:233–241. [PMC free article] [PubMed]
  37. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008;269:199–225. [PubMed]
  38. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009;9:302–312. [PubMed]
  39. Tse C, Xiang RH, Bracht T, Naylor SL. Human semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 2002;62:542–6. [PubMed]
  40. Atwal JK, Singh KK, Tessier-Lavigne M, Miller FD, Kaplan DR. Semaphorin 3F antagonizes neurotrophin-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase signaling: a mechanism for growth cone collapse. J Neurosci 2003;23:7602–9. [PubMed]
  41. Rieger J, Wick W, Weller M. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 2003;42:379–89. [PubMed]

3. Purchase this article at rate $33.00

For any technique error please contact us 

Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,...

Find out more

Review Article
DOI: http://dx.doi.org/10.18081/2333-5106/014-04/247-259
American Journal of BioMedicine 2014, Volume 2, Issue 4, pages 247-259
Received 29 May 2014; accepted October 10, 2014, Published November 03, 2014

How to cite this article
Wang DG, Yousif NG, Sadiq AM, Schilling MM, Danielson AJ. Critical role of SEMA5A expression in invasion and metastasis of ovarian cancer cell. American Journal of BioMedicine 2014;2(4):247-259

Case report outline
1. Abstract
2. Keywords
3. Introduction
4. Methods
5. Results
6. Discussion
7. References

Article metric